Market Outlook Snapshot Market Dynamics Regional Forecast Country Insights Segment Analysis Competitive Landscape Industry News report.faq_name
On This Report

Vital Signs Monitoring Devices Market Size & Growth Forecast 2026–2035, By Segments (Product, End-use), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape

Report ID: FBI 6674| Published Date: Feb-2026| Format: PDF, Excel
MARKET OUTLOOK

Market Size and Growoth Outlook

Vital Signs Monitoring Devices Market size stood at USD 11.92 Billion in 2025 and is predicted to grow at a 9.6% CAGR from 2026 to 2035, exceeding USD 29.81 Billion by 2035. The industry revenue for 2026 is estimated at USD 12.91 billion.

Base Year Value (2025)
USD 11.92 Billion
CAGR (2026-2035)
9.6%
Forecast Year Value (2035)
USD 29.81 Billion
Historical Data Period
2022-2025
Largest Region
North America
Forecast Period
2026-2035

Get more details on this report

Request Free Sample Report
SNAPSHOT

Vital Signs Monitoring Devices Market Intelligence Snapshot

Regional Market Dynamics

  • North America held a 43.78% market share in 2025, supported by widespread deployment across hospitals, ambulatory care, and home settings, along with strong demand for connected monitoring systems.
  • Asia Pacific is expected to grow at a 10.85% CAGR, driven by expanding healthcare access, wider use of portable and remote monitoring, and increasing demand for chronic disease management.

Segment Momentum

  • Blood Pressure Monitors remain the leading product because they are routinely used across hospitals, outpatient care, and home settings for convenient, repeatable monitoring and long-term health tracking.
  • Homecare Settings are growing fastest as patients and caregivers increasingly prefer convenient, ongoing vital sign monitoring outside hospitals, supporting flexible long-term observation without frequent facility visits.

Market Expansion Drivers

  • Rising home healthcare adoption increasing demand for wearable and remote monitoring devices.
  • Growing prevalence of chronic diseases accelerating continuous vital signs monitoring deployment.
  • Expansion of telehealth and predictive analytics enhancing connected patient monitoring ecosystems.

Leading Market Participants

FORECAST SNAPSHOT

Global Market Forecast Snapshot

Market Outlook

Leading players in the vital signs monitoring devices market include Koninklijke Philips N.V. (Netherlands), Medtronic plc (Ireland), GE HealthCare Technologies Inc. (United States), Nihon Kohden Corporation (Japan), Masimo Corporation (United States), Omron Healthcare Co., Ltd. (Japan), Nonin Medical, Inc. (United States), Halma plc (SunTech Medical, Inc.) (United States), CONTEC Medical Systems Co., Ltd. (China), A&D Company, Limited (Japan).

Regional and Segment Outlook

North America
MARKET DYNAMICS

Market Growth Drivers and Industry Trends

Rising home healthcare adoption increasing demand for wearable and remote monitoring devices

As more care shifts from hospitals to residential settings, the vital signs monitoring devices market is seeing stronger demand for compact, easy-to-use wearables and remote monitoring systems that allow clinicians to track patients without in-person visits. Providers and payers increasingly rely on home-based recovery, post-acute management, and elderly care models that require continuous visibility into blood pressure, pulse rate, oxygen saturation, and temperature trends. This changes purchasing behavior toward connected devices with wireless data transmission, longer battery life, and simplified interfaces, increasing demand for solutions designed for routine use by patients and caregivers rather than trained clinical staff.

Growing prevalence of chronic diseases accelerating continuous vital signs monitoring deployment

The rising burden of conditions such as cardiovascular disease, diabetes, and respiratory disorders is pushing care teams toward continuous rather than episodic monitoring, supporting market expansion for devices that can capture early physiological changes before they develop into acute events. In the vital signs monitoring devices market, chronic disease management is increasing adoption of multi-parameter monitors and wearable sensors that fit into long-term care pathways, outpatient management, and readmission reduction strategies. Demand is shaped less by one-time diagnostic use and more by the need for ongoing data streams that help physicians adjust treatment plans, identify deterioration earlier, and manage high-risk patient populations more closely.

Expansion of telehealth and predictive analytics enhancing connected patient monitoring ecosystems

The expansion of virtual care is supporting market development in the vital signs monitoring devices market by making connected monitoring hardware a practical extension of telehealth consultations rather than a standalone device purchase. As providers build remote care workflows, devices that integrate with digital platforms, electronic health records, and analytics tools become more valuable because they turn real-time vital signs data into alerts, triage inputs, and longitudinal patient insights. Predictive analytics reinforces this shift by increasing preference for interoperable monitoring systems that can support risk stratification and earlier intervention, influencing procurement toward platforms that combine sensors, connectivity, and actionable data interpretation.

Growth Driver Impact on CAGR Regulatory Influence Geographic Relevance Adoption Rate Impact Timeline
Rising home healthcare adoption increasing demand for wearable and remote monitoring devices 2.00% Moderate North America, Asia Pacific High Near Term
Growing prevalence of chronic diseases accelerating continuous vital signs monitoring deployment 1.80% Moderate North America, Europe High Mid Term
Expansion of telehealth and predictive analytics enhancing connected patient monitoring ecosystems 1.50% High Asia Pacific, North America Emerging Mid Term
CUSTOM RESEARCH

Unlock insights tailored to your business with our bespoke market research solutions.

Click to get your customized report now.

Request Customization →
REGIONAL FORECAST

Regional Demand Dynamics

Polymer Modified Bitumen Market
Largest Region
North America
43.78% Market Share in 2025
North America (Largest Region) vs Asia Pacific (Fastest-Growing Region)

North America held the leading position in 2025, accounting for a 43.78% share of the vital signs monitoring devices market. This leadership is sustained by broad deployment of monitoring equipment across hospitals, ambulatory care settings, and home-based care, where continuous measurement of parameters such as blood pressure, pulse rate, oxygen saturation, and temperature is integrated into routine patient management. The region’s market activity is further bolstered by established clinical workflows, strong uptake of connected monitoring systems, and consistent device replacement demand from healthcare providers seeking reliable, real-time patient data.

Asia Pacific is set to record a 10.85% CAGR over the forecast period in the vital signs monitoring devices market, driven by expanding healthcare access and rising adoption of patient monitoring technologies across both acute and non-acute care settings. Growth is accelerating as healthcare systems add capacity, providers increase use of portable and remote monitoring solutions, and demand rises for earlier detection and ongoing management of chronic and age-related conditions. In practice, this is translating into wider installation of monitoring devices in hospitals and clinics as well as stronger uptake in home care environments where cost-effective, easy-to-use systems support ongoing observation outside traditional care facilities.

Parameter North America Asia Pacific Europe Latin America MEA
Innovation Hub i Scale Nascent Developing Advanced
Cost-Sensitive Region i Scale Low Medium High
Regulatory Environment i Scale Restrictive Neutral Supportive
Demand Drivers i Scale Weak Moderate Strong
Development Stage i Scale Emerging Developing Developed
Adoption Rate i Scale Low Medium High
New Entrants / Startups i Scale Sparse Moderate Dense
Macro Indicators i Scale Weak Stable Strong
COUNTRY INSIGHTS

Key Country Insights

Germany 🇩🇪

Clinical Precision Focus

Germany emphasizes high-accuracy vital signs monitoring devices that support intensive care, surgical environments, and digital hospital initiatives. Procurement decisions increasingly favor reliable performance, regulatory compliance, and seamless integration with clinical infrastructure.

France 🇫🇷

Hospital Modernization Support

France invests in vital signs monitoring devices that strengthen hospital modernization and outpatient care delivery. Healthcare providers prioritize dependable monitoring platforms that improve patient safety while supporting efficient resource utilization across healthcare networks.

Italy 🇮🇹

Critical Care Enhancement

Italy focuses on upgrading vital signs monitoring devices for emergency departments, intensive care units, and post-acute care facilities. Hospitals increasingly seek flexible monitoring solutions that enhance patient surveillance while supporting efficient clinical workflows.

Japan 🇯🇵

Aging Care Integration

Japan expands the use of vital signs monitoring devices to support elderly care, chronic disease management, and hospital automation. Healthcare providers increasingly adopt compact, dependable systems that enable continuous patient observation while easing workforce constraints.

South Korea 🇰🇷

Smart Hospital Deployment

South Korea advances vital signs monitoring devices through smart hospital programs and digitally connected healthcare facilities. Local demand favors AI-enabled monitoring capabilities, wireless connectivity, and rapid data exchange that improve clinical decision-making.

United States 🇺🇸

Connected Care Adoption

The U.S. prioritizes vital signs monitoring devices that integrate with hospital information systems and remote patient monitoring platforms. Demand is centered on continuous monitoring, interoperability, and workflow efficiency across acute care and home healthcare settings.

SEGMENT ANALYSIS

Segment Leadership and Growth Trends

Vital Signs Monitoring Devices Market Share (%), Product, 2025

Blood Pressure Monitors
Pulse Oximeters
Temperature Monitors
Others

Go beyond the chart, access full insights & data tables

Request Free Sample Report
Product Segment Analysis: Blood Pressure Monitors (Largest & Fastest-Growing Segment)

Blood Pressure Monitors held the largest share of the vital signs monitoring devices market in 2025, and the segment continues to expand faster than alternatives because blood pressure measurement remains one of the most routine and necessary checks across clinical and non-clinical settings. its position is sustained by broad use in hospitals, outpatient care, and personal health management, where regular monitoring is practical, familiar, and easy to integrate into daily workflows. The same broad applicability is driving ongoing growth in the vital signs monitoring devices market, as demand continues to rise for convenient monitoring tools that support repeated measurement, early detection, and long-term tracking outside traditional care environments.

End-use Segment Analysis: Hospitals (Largest Segment) vs Homecare Settings (Fastest-Growing Segment)

Hospitals accounted for the largest share of the vital signs monitoring devices market in 2025, backed by the constant need for continuous patient observation across emergency care, surgery, intensive care, and general inpatient settings. This leadership is sustained by the high volume of monitored patients and the routine use of multiple vital signs monitoring devices as part of standard clinical protocols. Hospitals also remain the primary setting for acute and complex cases, which keeps device utilization consistently high and reinforces their leading share in the market.

Homecare Settings are emerging as the fastest-growing end-use segment in the vital signs monitoring devices market as monitoring increasingly shifts closer to the patient. Growth is being influenced by the practical need for regular vital sign tracking outside hospitals, especially where users and caregivers want convenient, repeatable monitoring without depending on facility-based visits. Compared with institutional settings, homecare gains momentum from its ability to support ongoing observation in a more flexible environment, making it an increasingly attractive use case for routine and long-duration monitoring.

Segment Sub-Segment Largest Segment Fastest Growing
Product Blood Pressure Monitors, Pulse Oximeters, Temperature Monitors, Others Blood Pressure Monitors Blood Pressure Monitors
End-use Hospitals, Homecare Settings, Ambulatory Surgical Centers, Others Hospitals Homecare Settings
Competitive Landscape

Competitive Landscape and Market Positioning

Key companies in the vital signs monitoring devices market:

1. Koninklijke Philips N.V. (Netherlands)

2. Medtronic plc (Ireland)

3. GE HealthCare Technologies Inc. (United States)

4. Nihon Kohden Corporation (Japan)

5. Masimo Corporation (United States)

6. Omron Healthcare Co. Ltd. (Japan)

7. Nonin Medical Inc. (United States)

8. Halma plc (SunTech Medical Inc.) (United States)

9. CONTEC Medical Systems Co. Ltd. (China)

10. A&D Company Limited (Japan)

The vital signs monitoring devices market is evolving through advancements in real-time patient monitoring technologies. Increasing adoption of wearable health devices is improving continuous care capabilities. Continuous innovation in sensor-based systems is enhancing diagnostic accuracy, while integration into healthcare networks is strengthening remote monitoring efficiency.

Company Market Share Company Revenue Revenue CAGR (%) Product Portfolio Geographic Presence Innovation / R&D Focus Strategic Developments
No companies available.
🔒 This section is available as a standalone purchase. Buy only the data you need. Inquire Before Buying
Industry News

Industry Development/News

Company Name Date Key Development
Cardinal Health Jun-25 Cardinal Health launched the Kendall DL™ Multi System, a single-patient use cable and lead wire solution. This device enables continuous monitoring of cardiac activity, blood oxygen levels, and temperature through a single connection point, streamlining clinical workflows and reducing the risk of cross-contamination associated with reusable lead wires in high-acuity hospital settings.
Zynex May-25 Zynex, Inc. submitted a 510(k) application to the U.S. FDA for its NiCO™ non-invasive laser CO-oximeter. This laser-based technology aims to improve pulse oximetry accuracy across diverse patient skin pigments by measuring all four primary hemoglobin species, potentially setting a new standard for reliable real-time oxygenation status monitoring in hospital and non-hospital care environments.
BioIntelliSense Feb-25 BioIntelliSense partnered with Hicuity Health to provide an end-to-end continuous patient monitoring solution. By integrating the BioButton® multi-parameter wearable and BioDashboard™ clinical intelligence system with Hicuity’s 24/7 virtual nursing services, the partnership enables health systems to scale remote monitoring from hospital wards to home-care settings while mitigating clinical staffing shortages.
GE Healthcare Apr-24 GE Healthcare received U.S. FDA approval for its Portrait VSM, a vital signs monitor designed to enhance clinical decision-making. The device facilitates rapid, accurate, and automated spot-check measurements, allowing clinicians to view a comprehensive dashboard of a patient’s condition, thereby improving the efficiency of routine patient assessments and reducing documentation time in hospital environments.
Masimo Corporation Jun-23 Masimo received FDA approval for its Radius VSM, a patient-worn, continuous multi-parameter vital signs monitor. The device enables the integration of Masimo SET® pulse oximetry, noninvasive blood pressure, temperature, respiration rate, and ECG monitoring into a single wearable form factor, facilitating flexible, high-acuity monitoring without tethering patients to bedside monitors.
Medtronic Aug-22 Medtronic established an exclusive U.S. distribution partnership with BioIntelliSense to offer the BioButton® multi-parameter wearable for continuous patient monitoring. This collaboration expanded Medtronic’s patient monitoring division into the remote and post-acute care segment, enabling hospitals to extend clinical oversight beyond the hospital stay to high-risk patients during the 30-day post-discharge recovery period.
Hillrom Jun-20 Hillrom launched its Extended Care Solution, a connected remote monitoring device designed to support the transition of care from hospital settings to the home. By utilizing wearable sensing technology to track vital signs, the system allows clinicians to proactively identify physiological deterioration in chronic care patients, effectively shifting the site of care to lower-cost, home-based environments.
Report Customization

Explore This Report

Click a section of the wheel — or its numbered marker — to preview the custom segmentation, custom table of contents, or related reports available for this market.

1 report.custom report.segments 2 Custom TOC 3 Related Reports

Vital Signs Monitoring Devices Market — Custom Segments

Segment Sub-Segment
No segment data available.

Vital Signs Monitoring Devices Market — report.custom

Custom Chapter Custom Details
No custom TOC data available.

Need a different cut of the data?

Request Custom Research
report.faq_name

What is the market valuation of vital signs monitoring devices?

The market size of the vital signs monitoring devices is estimated at USD 12.91 billion in 2026.

What is the projected value of the vital signs monitoring devices industry by 2035?

Vital Signs Monitoring Devices Market size is expected to advance from USD 11.92 billion in 2025 to USD 29.81 billion by 2035 registering a CAGR of more than 9.6% across 2026-2035.

How is the shift toward home healthcare affecting demand for vital signs monitoring devices?

Home healthcare expansion is increasing demand for wearable, easy-to-use monitoring devices with remote connectivity, enabling continuous patient tracking outside hospitals and shifting purchasing toward patient-friendly, digitally connected systems.

How are chronic diseases influencing long-term adoption of continuous monitoring solutions?

Rising chronic disease prevalence is driving demand for continuous multi-parameter monitoring, supporting long-term patient management models that rely on real-time physiological data for early intervention and treatment adjustment.

Why do Blood Pressure Monitors lead the vital signs monitoring devices market?

Blood Pressure Monitors remain the leading product because they are routinely used across hospitals, outpatient care, and home settings for convenient, repeatable monitoring and long-term health tracking.

Why are Homecare Settings the fastest-growing end-use segment in the vital signs monitoring devices market?

Homecare Settings are growing fastest as patients and caregivers increasingly prefer convenient, ongoing vital sign monitoring outside hospitals, supporting flexible long-term observation without frequent facility visits.

Why does North America dominate the vital signs monitoring devices market?

North America held a 43.78% market share in 2025, supported by widespread deployment across hospitals, ambulatory care, and home settings, along with strong demand for connected monitoring systems.

What is driving growth in the vital signs monitoring devices market in Asia Pacific?

Asia Pacific is expected to grow at a 10.85% CAGR, driven by expanding healthcare access, wider use of portable and remote monitoring, and increasing demand for chronic disease management.

Which companies dominate the vital signs monitoring devices landscape?

Leading players in the vital signs monitoring devices market include Koninklijke Philips N.V. (Netherlands), Medtronic plc (Ireland), GE HealthCare Technologies Inc. (United States), Nihon Kohden Corporation (Japan), Masimo Corporation (United States), Omron Healthcare Co., Ltd. (Japan), Nonin Medical, Inc. (United States), Halma plc (SunTech Medical, Inc.) (United States), CONTEC Medical Systems Co., Ltd. (China), A&D Company, Limited (Japan).
Testimonials

Our Clients

"The reports offered a comprehensive view of the Food and Beverage landscape, covering market trends, consumer behavior, and competitive dynamics."

Quality Assurance Manager

"Our experience in acquiring market research reports has been outstanding — the depth of analysis and actionable insights have proven invaluable."

R&D Manager

"Fundamental Business Insights demonstrated a keen understanding of our business needs, delivering reports tailored to our specific objectives."

Senior Marketing Manager
THE RESEARCH BEHIND THIS REPORT

Our Research Team & Methodology

Every Fundamental Business Insights report is built by a dedicated vertical research team, validated through a structured primary-and-secondary methodology, and reviewed for accuracy before it reaches you.

THIS REPORT'S RESEARCH VERTICAL

Research Team Overview

♢
This report was prepared by the Healthcare & Medical Devices Research Team at Fundamental Business Insights, a dedicated research group specializing in the global healthcare and medical technology industry. Our analysts continuously monitor advancements in medical technologies, clinical adoption trends, regulatory developments, reimbursement policies, healthcare infrastructure investments, competitive strategies, and evolving patient care requirements to deliver timely and reliable market intelligence. The research is developed using a structured methodology that combines primary discussions with healthcare stakeholders, company financial disclosures, regulatory publications, clinical literature, government healthcare databases, medical associations, and other authoritative secondary sources. Market estimates are validated through multiple research techniques, including top-down and bottom-up analysis, before undergoing an internal quality review to ensure accuracy, consistency, and methodological integrity prior to publication.

Prepared by the Healthcare & Medical Devices Research Team

10+
Industry Verticals
100+
Countries Analyzed
5–7
Days Standard
Delivery
12k+
Research Reports
Published
On-
Demand
Customized Research
Available
6
Months Analyst
Support
PDF + XLS
Report Deliverables

Trust & Compliance

☷D&B D-U-N-S
♢GDPR & CCPA Compliant
♙ISO 9001 Certified (ISO 9001:2015)
♙SSL Encryption
▭Secure Payments
✓Confidential Handling

Research Domains

10 coverage areas
Medical Devices & Equipment Diagnostic Imaging Clinical Diagnostics Digital Health & Telemedicine Patient Monitoring Systems Surgical & Minimally Invasive Technologies Healthcare IT & Data Systems Biotechnology & Life Sciences Pharmaceutical Technologies Healthcare Delivery & Services

Research Intelligence

Executive Leadership
Product & Technology Experts
Manufacturing & Operations Leaders
Procurement & Supply Chain Professionals
Sales & Commercial Executives
Channel Partners & Distribution Networks
Enterprise Buyers & End Users
Industry Consultants & Regulatory Experts

Research Workflow & Quality Assurance

📥
01

Data Collection

Verified information gathered through primary and secondary research.

🔍
02

Data Triangulation

Cross-validation using multiple independent data sources.

📈
03

Forecast Modelling

Market estimates developed using historical trends and analytical models.

👨‍💼
04

Analyst Validation

Findings reviewed by domain experts for accuracy and consistency.

📝
05

Editorial & Quality Review

Final editorial, quality, and compliance checks before publication.

✅
06

Final Publication

Released after successful completion of the internal review process.

Report Coverage

📊 Market Assessment

  • Market Size & Forecast
  • Market Segmentation
  • Regional Analysis
  • Growth Drivers & Challenges
  • Market Dynamics

🏢 Competitive Intelligence

  • Competitive Landscape
  • Company Profiles
  • Competitive Benchmarking
  • Mergers & Acquisitions
  • Market Share Analysis or Key Company Strategies

🔍 Strategic Analysis

  • Value Chain Analysis
  • Porter's Five Forces
  • PESTLE Analysis
  • Pricing Trends
  • Supply-Demand Analysis

🚀 Future Outlook

  • Technology Landscape
  • Regulatory Landscape
  • Investment & Funding Landscape
  • Emerging Opportunities
  • Future Market Outlook

Have a question about this report or need a custom scope?

Request Customization
License

Select License Type

Single User
US$ 4,250
Buy Now
Corporate User
US$ 6,150
Buy Now

Want this data scoped to your exact question?

Tell us the segments, regions, or competitors you need answered — an analyst will confirm scope before any custom work starts.

Talk to an Analyst →